Biedermann A, Patra-Kneuer M, Mougiakakos D, Buttner-Herold M, et al. Blockade of the CD47/SIRPalpha checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. Haematologica 2024;109:3928-3940.
PMID: 38934068